| 000 | 02482 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250515215548.0 | ||
| 264 | 0 | _c20100507 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1546-1726 | ||
| 024 | 7 |
_a10.1038/nn.2517 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Jimok | |
| 245 | 0 | 0 |
_aReduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. _h[electronic resource] |
| 260 |
_bNature neuroscience _cMay 2010 |
||
| 300 |
_a592-600 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAgatoxins |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acids _xpharmacology |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aBenzoxazines _xpharmacology |
| 650 | 0 | 4 | _aBiophysics |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xmetabolism |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 |
_aConotoxins _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aElectric Stimulation _xmethods |
| 650 | 0 | 4 | _aEndocannabinoids |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aGlycerides _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xcytology |
| 650 | 0 | 4 |
_aHomeostasis _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInhibitory Postsynaptic Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aNerve Net _xphysiology |
| 650 | 0 | 4 |
_aNeural Inhibition _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPatch-Clamp Techniques _xmethods |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPolyamines _xpharmacology |
| 650 | 0 | 4 |
_aPolyunsaturated Alkamides _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xagonists |
| 650 | 0 | 4 | _aRimonabant |
| 650 | 0 | 4 |
_aSodium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aSynapses _xdrug effects |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aAlger, Bradley E | |
| 773 | 0 |
_tNature neuroscience _gvol. 13 _gno. 5 _gp. 592-600 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nn.2517 _zAvailable from publisher's website |
| 999 |
_c19709884 _d19709884 |
||